C Ferrari, G Santo, P Mammucci, AR Pisani, A Sardaro… - Biomedicines, 2021 - mdpi.com
Hyperparathyroidism is a metabolic disorder characterized by the excessive production of the parathyroid hormone. The diagnosis is based on clinical and laboratory data. In most …
J Whitman, IE Allen, EK Bergsland, I Suh… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Hyperparathyroidism is an endocrine disorder caused by one or more hyperfunctioning parathyroid glands. Current imaging consisting of ultrasound and 99mTc-sestamibi is …
KA Iwen, J Kußmann, V Fendrich, K Lindner… - World Journal of …, 2022 - Springer
Background Primary hyperparathyroidism (pHPT) is well treatable surgically. Sonography (US) and sestamibi scintigraphy (MIBI) are used routinely, but it is unclear how valuable they …
C Mathey, C Keyzer, D Blocklet… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Preoperative molecular imaging is paramount to direct surgery in primary hyperparathyroidism (pHPT). We investigated the diagnostic performance of 18F …
L Noskovicova, S Balogova, C Aveline… - Seminars in Nuclear …, 2024 - Elsevier
In patients with confirmed hyperparathyroidism (HPT) scheduled for surgical treatment, the preoperatory imaging permits to optimize the operatory protocol of parathyroidectomy (PTX) …
SJ Kim, DM Shoback - Endocrinology and Metabolism Clinics, 2021 - endo.theclinics.com
Primary hyperparathyroidism (PHPT) is due to an increased secretion of parathyroid hormone (PTH) by 1 or more parathyroid glands, characterized by hypercalcemia and …
Background: Primary hyperparathyroidism (PHPT) in the most common and earliest manifestation of multiple endocrine neoplasia type-1 (MEN1). Epidemiological data have …
E Bouilloux, N Santucci, A Bertaut, JL Alberini… - Academic …, 2024 - Elsevier
Rationale and Objectives This study evaluated the diagnostic performance of 18 F- fluorocholine (FCH) PET/CT as the first-line functional imaging method for preoperative …